Agilent

home / authors / agilent-1

Articles

Elevating Your Charge Variant and Aggregate Analysis for Biotherapeutic Proteins

Elevating Your Charge Variant and Aggregate Analysis for Biotherapeutic Proteins

Agilent
March 22nd 2021

*Monday, March 22, 2021 at 9am EDT| 1pm GMT | 2pm CET, Monday, March 22, 2021 at 2pm EDT| 1pm CDT | 11am PDT* High resolution is one of the key challenges in modern biopharmaceutical analysis. In this webinar learn the importance of considering the entire liquid chromatography (LC) system to gain optimum results and maximum resolution from your LC column. *On demand available after final airing until March 22, 2022*

Site Logo

Application Note: Isolate and Reanalyze Pharma Impurities with the Agilent 1290 Infinity II Autoscale Preparative LC/MSD System

Agilent
January 18th 2021
Site Logo

Application Note: Improved Lifetime of Bio-Monolith Protein A Columns for Titer Determination

Agilent
January 18th 2021
Site Logo

Application Note: High Salt—High Reproducibility Analysis of antibody drug conjugates using hydrophobic interaction chromatography with the Agilent 1290 Infinity II Bio LC System

Agilent
January 18th 2021
Site Logo

Application Note: An Improved Workflow for Profiling and Quantitation of Sialic Acids in Biotherapeutics

Agilent
January 18th 2021
Site Logo

Application Note: Analysis of a Synthetic Peptide and Its Impurities Using mass spectrometry compatible mobile phases with an Agilent AdvanceBio Peptide Plus column

Agilent
January 18th 2021
Site Logo

Application Note: Elevate Your mAb Aggregate Analysis: High-resolution SEC with the Agilent 1290 Infinity II Bio LC System

Agilent
January 18th 2021
Site Logo

Application Note: Mass Spectrometric Characterization of Antibody-siRNA Conjugates using the Agilent 6545XT AdvanceBio LC/Q-TOF

Agilent
January 18th 2021
Site Logo

Application Note: Analysis of Camelid Single-Domain Antibodies Using Agilent AdvanceBio SEC 120 Å 1.9 µm and AdvanceBio HIC Columns

Agilent
January 18th 2021
Site Logo

Application Note: Seamless Method Transfer to the Agilent 1290 Infinity II Bio LC System Peptide-mapping analysis shows excellent performance and high method compatibility compared to the Agilent 1290 Infinity II LC System

Agilent
January 18th 2021
Site Logo

Application Note: How Shallow Can You Go? Refining charge variant analysis of mAbs with the Agilent 1290 Infinity II Bio LC System

Agilent
January 18th 2021
Site Logo

Automated 4D-LC/MS Characterization of mAbs

Agilent
December 11th 2020

4D-LC/MS allows characterization of mAbs by cation-exchange chromatography followed by online desalting, denaturation, reduction, tryptic digestion and peptide mapping.

Site Logo

Development of a Rapid 2-AB Sample Preparation Workflow for N-Glycan Release and Labeling

Agilent
October 20th 2020
Site Logo

N-Glycan Analysis: Better Together

Agilent
October 20th 2020
Site Logo

Glycopeptide Characterization for Various Monoclonal Antibodies Using the Agilent 6545XT AdvanceBio LC/Q-TOFXT AdvanceBio LC/Q‑TOF

Agilent
October 20th 2020
Site Logo

Profiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 6545XT AdvanceBio LC/Q‑TOF

Agilent
October 20th 2020
Site Logo

Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides

Agilent
October 16th 2020
Site Logo

High Performance DNA Oligonucleotide Purification Using Agilent TOP-DNA

Agilent
October 16th 2020
Site Logo

High Resolution Separations of Oligonucleotides Using PL-SAX Strong Anion-Exchange HPLC Columns

Agilent
October 16th 2020
Site Logo

Evaluation of New High pH Stable, Superficially-porous Particle Columns for the Reversed-phase Separation of Oligonucleotides

Agilent
October 16th 2020
Site Logo

Direct Analysis of In-Process Oligonucleotides Without Manual Purification

Agilent
October 16th 2020
Site Logo

Fundamentals of Oligonucleotide Separation by HPLC

Agilent
October 16th 2020
Site Logo

Clear Advantages for Characterizing Critical Quality Attributes (CQAs) of Biopharmaceutical Products

Agilent
August 9th 2019

• Streamlined separations for intact proteins, peptide mapping, glycans analysis • LC/Q-TOF enhanced workflows

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
The Pharmacy Advantage in Direct-to-Patient Clinical Supply
Published: November 22nd 2024 | Updated: November 26th 2024
The Pharmacy Advantage in Direct-to-Patient Clinical Supply
Published: October 28th 2024 | Updated: November 26th 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 15th 2024 | Updated: November 26th 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 26th 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
© 2024 MJH Life Sciences

All rights reserved.